Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Atyr Pharma Inc (NQ: LIFE ) 1.600 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.600 Bid (Size) 1.550 (1) Ask (Size) 1.980 (1) Prev. Close 1.600 Today's Range 1.600 - 1.600 52wk Range 1.080 - 2.700 Shares Outstanding 54,291,754 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Tuesday's After-Market Session April 09, 2024 Via Benzinga aTyr Pharma to Participate in April Investor Conferences April 01, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Performance YTD +7.02% +7.02% 1 Month -16.23% -16.23% 3 Month -1.23% -1.23% 6 Month +28.00% +28.00% 1 Year -23.81% -23.81% More News Read More 3 Penny Stocks That Could Be Multibaggers in the Making: March Edition March 26, 2024 Via InvestorPlace LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023 March 14, 2024 Via InvestorPlace Recap: aTyr Pharma Q4 Earnings March 14, 2024 Via Benzinga aTyr Pharma's Earnings Outlook March 13, 2024 Via Benzinga Analyst Expectations for aTyr Pharma's Future September 21, 2023 Via Benzinga The Latest Analyst Ratings for aTyr Pharma May 23, 2023 Via Benzinga aTyr Pharma: Q1 Earnings Insights May 09, 2023 Via Benzinga aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update March 14, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Earnings Scheduled For March 14, 2024 March 14, 2024 Via Benzinga aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results February 28, 2024 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants February 21, 2024 From aTyr Pharma, Inc. Via GlobeNewswire The 3 Best Penny Stocks to Buy in February 2024 February 15, 2024 Via InvestorPlace aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity January 29, 2024 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor January 18, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition! November 13, 2023 Via IssueWire Topics Religion Exposures Religion aTyr Pharma to Present at November Investor Conferences November 01, 2023 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD October 31, 2023 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes September 11, 2023 From aTyr Pharma, Inc. Via GlobeNewswire $12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying August 02, 2023 Via Benzinga aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst July 05, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023 July 05, 2023 Via Benzinga 7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023 June 28, 2023 Via InvestorPlace 3 Stocks and Cryptos With the Highest Potential Returns May 07, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.